HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S., European Nanotech Programs Move Regulations Closer To Global Model

This article was originally published in The Tan Sheet

Executive Summary

The regulation of nanotechnology continues moving toward a harmonized model as agencies on both sides of the Atlantic announce research funding and collaborations toward safety assessments.

You may also be interested in...



FDA Nanotech Guidance Takes Small Step Forward

FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.

President's Budget Proposal Points To Expanding FDA User Fees

President Obama's fiscal 2012 budget request concurs with FDA in recommending that Congress expand the type of user fees that industry pays for food safety enforcement reform.

FDA Science Board Recommends Larger Nanotech Program Budget

FDA Science Board members say the $7.3 million the agency requested for its first dedicated budget for nanotechnology is not enough

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel